SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-334428
Filing Date
2021-11-19
Accepted
2021-11-19 06:08:55
Documents
13
Period of Report
2021-11-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d233272d8k.htm   iXBRL 8-K 29482
2 EX-10.1 d233272dex101.htm EX-10.1 178590
  Complete submission text file 0001193125-21-334428.txt   375821

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mirm-20211116.xsd EX-101.SCH 2889
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20211116_lab.xml EX-101.LAB 18888
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20211116_pre.xml EX-101.PRE 11858
6 EXTRACTED XBRL INSTANCE DOCUMENT d233272d8k_htm.xml XML 3478
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 211426333
SIC: 2834 Pharmaceutical Preparations